Literature DB >> 9061804

Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers.

A Aluoja1, J Shlik, V Vasar, P H Kingisepp, K Jagomägi, E Vasar, J Bradwejn.   

Abstract

This article examines the effect of baseline anxiety, anxiety sensitivity and dysfunctional attitudes on the response to cholecystokinin tetrapeptide (CCK-4) in healthy volunteers. CCK-4 and placebo were administered to 14 subjects in a double-blind manner. Four volunteers experienced a panic attack after CCK-4 administration. Those subjects who panicked had significantly higher baseline scores on dysfunctional attitudes. Dysfunctional thought patterns appeared also to predict number of symptoms and experience of cognitive and affective symptoms during injection. Baseline anxiety as well as anxiety sensitivity predicted reactions to placebo but not panic responses to CCK-4. Results suggest that a general tendency towards erroneous interpretation of information has some role in mediating the panicogenic effects of CCK-4, and also interpersonal sensitivity may constitute a vulnerability factor for panic. Psychological factors that have been considered more specific to panic disorder, namely high state and trait anxiety as well as anxiety sensitivity, appeared mainly to determine general reactions to a threatening situation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9061804     DOI: 10.1016/s0165-1781(96)02948-4

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers.

Authors:  Daniela Eser; Gregor Leicht; Jürgen Lutz; Stephan Wenninger; Valerie Kirsch; Cornelius Schüle; Susanne Karch; Thomas Baghai; Oliver Pogarell; Christine Born; Rainer Rupprecht; Christoph Mulert
Journal:  Hum Brain Mapp       Date:  2009-02       Impact factor: 5.038

2.  Impact of state and trait anxiety on the panic response to CCK-4.

Authors:  Daniela Eser; Stephan Wenninger; Thomas Baghai; Cornelius Schüle; Rainer Rupprecht
Journal:  J Neural Transm (Vienna)       Date:  2008-04-15       Impact factor: 3.575

3.  Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women.

Authors:  Helena Hedström; Marie Bixo; Sigrid Nyberg; Olav Spigset; Elisabeth Zingmark; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2008-10-24       Impact factor: 4.530

4.  Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.

Authors:  Santiago J Ballaz; Michel Bourin; Huda Akil; Stanley J Watson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-09-14       Impact factor: 5.067

5.  Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study.

Authors:  Daniela Eser; Cornelius Schüle; Thomas Baghai; Anette Floesser; Axel Krebs-Brown; Michaela Enunwa; Stephan de la Motte; Rolf Engel; Klaus Kucher; Rainer Rupprecht
Journal:  Psychopharmacology (Berl)       Date:  2007-02-23       Impact factor: 4.415

Review 6.  Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.

Authors:  Santiago J Ballaz; Michel Bourin
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.